NSE · Healthcare · Medical Care Facilities
| Document | Date |
|---|---|
| Annual report FY2026 GAUDIUM IVF AND WOMEN HEALTH LIMITED - ANNUAL REPORT FY 2025-26 SUMMARY HEADLINE NUMBERS • Revenue from operations: ₹10,435.70 lakhs (FY 2024-25: ₹7 | 2026-09-03 |
| Q1 FY27 earnings call GAUDIUM IVF AND WOMEN HEALTH LIMITED - Q1 FY27 SUMMARY HEADLINE NUMBERS • Q1 FY27 Revenue: ₹19.4 crores (consolidated), up 9.1% YoY from ₹17.8 crore | 2026-08-19 |
| Investor presentation · Q1 FY27 GAUDIUM IVF AND WOMEN HEALTH LIMITED – Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from Operations (Standalone): Rs 1,367.73 lakhs in Q1 FY2 | 2026-08-14 |
| Quarterly results · Q1 FY27 GAUDIUM IVF AND WOMEN HEALTH LIMITED – Q1FY27 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1FY27 Revenue from Operations: ₹19.4 Crore (vs ₹17.8 Crore in Q1 | 2026-08-13 |
| Investor presentation | 2026-08-13 |
| Quarterly results · Q4 FY26 GAUDIUM IVF AND WOMEN HEALTH LIMITED – FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Standalone Revenue FY 2025-26: ₹7,157.85 Lakhs (vs ₹5,900.16 Lak | 2026-06-25 |
| Investor presentation · Q4 FY26 | 2026-05-29 |
| Quarterly results · Q3 FY26 GAUDIUM IVF AND WOMEN HEALTH LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 FY26 Revenue from operations: ₹2,450.70 lakh • Q3 FY26 Net Profit: ₹3 | 2026-03-19 |
Readable in the app.
| Announcement | Date |
|---|---|
| AI-powered signature labs and planned 19 centre expansion Gaudium IVF, India's first publicly listed IVF company, launched its first center as part of a planned 19-center expansion outlined during its IPO. The new South Delhi facility features the | 2026-07-16 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Gaudium IVF and Women Health Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.